Showing results (71-80 of 131) with videos related to

Sort By:
Pageof 14
Neurology|July 1, 1997
The impact of apolipoprotein E4 on cause of death in Alzheimer's diseaseJ M Olichney, M N Sabbagh, C R Hofstetter, et al.
International Journal of Geriatric Psychiatry|September 14, 2000
Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: a preliminary studyW Samuel, M Caligiuri, D Galasko, et al.
Neurology|July 1, 1996
The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variantJ M Olichney, L A Hansen, D Galasko, et al.
Neurology|February 1, 1993
Intramedullary spinal sarcoidosis: clinical and magnetic resonance imaging characteristicsS S Junger, B J Stern, S R Levine, et al.
AJR. American Journal of Roentgenology|November 1, 1987
MR and CT evaluation of intracranial sarcoidosisW S Hayes, J L Sherman, B J Stern, et al.
Archives of Neurology|July 15, 1999
Variability in annual Mini-Mental State Examination score in patients with probable Alzheimer disease: a clinical perspective of data from the Consortium to Establish a Registry for Alzheimer's DiseaseC M Clark, L Sheppard, G G Fillenbaum, et al.
Neurology|August 26, 1998
Cognitive decline is faster in Lewy body variant than in Alzheimer's diseaseJ M Olichney, D Galasko, D P Salmon, et al.
Neuroreport|December 14, 2001
Cholinergic deficits in the brains of patients with parkinsonism-dementia complex of GuamE Masliah, M Alford, D Galasko, et al.
Neurology|June 27, 2002
Cognitive profiles differ in autopsy-confirmed frontotemporal dementia and ADK Rascovsky, D P Salmon, G J Ho, et al.
Biological Psychiatry|September 24, 1999
Longitudinal stability of CSF tau levels in Alzheimer patientsT Sunderland, B Wolozin, D Galasko, et al.
Pageof 14